These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21447200)

  • 1. [Rheumatic diseases need more attention in case of the desire to have children and during pregnancy].
    de Man YA; Dolhain RJ; Steegers EA; Hazes JM
    Ned Tijdschr Geneeskd; 2011; 155(13):A2622. PubMed ID: 21447200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheumatic diseases in pregnancy].
    Märker-Hermann E; Bauer H; Gromnica-Ihle E
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rheumatic diseases during pregnancy].
    Fischer-Betz R
    Internist (Berl); 2012 Sep; 53(9):1047-53. PubMed ID: 22695896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Individual and interdisciplinary treatment of rheumatic diseases in pregnancy].
    Bolz M
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2415. PubMed ID: 18988135
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacotherapy in pregnancy and lactation in rheumatic diseases].
    Anić B; Cikes N
    Reumatizam; 2006; 53(2):55-8. PubMed ID: 17580555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.
    Furst DE; Keystone EC; So AK; Braun J; Breedveld FC; Burmester GR; De Benedetti F; Dörner T; Emery P; Fleischmann R; Gibofsky A; Kalden JR; Kavanaugh A; Kirkham B; Mease P; Rubbert-Roth A; Sieper J; Singer NG; Smolen JS; Van Riel PL; Weisman MH; Winthrop KL
    Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii2-34. PubMed ID: 23532441
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases.
    Elliott AB; Chakravarty EF
    Womens Health (Lond); 2010 May; 6(3):431-40; quiz 441-2. PubMed ID: 20426608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs.
    Østensen M; Lockshin M; Doria A; Valesini G; Meroni P; Gordon C; Brucato A; Tincani A
    Rheumatology (Oxford); 2008 Jun; 47 Suppl 3():iii28-31. PubMed ID: 18504282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy and rheumatic disease: "by the book" or "by the doc".
    Keeling SO; Oswald AE
    Clin Rheumatol; 2009 Jan; 28(1):1-9. PubMed ID: 18987777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs in pregnancy. Rheumatological disorders.
    Østensen M
    Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):953-69. PubMed ID: 11800535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.
    Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Bijlsma JW; Dougados M; Emery P; Keystone EC; Klareskog L; Mease PJ
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv2-14. PubMed ID: 16239380
    [No Abstract]   [Full Text] [Related]  

  • 12. Disease specific problems related to drug therapy in pregnancy.
    Ostensen M
    Lupus; 2004; 13(9):746-50. PubMed ID: 15485116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnancy in rheumatic patients treated with biologic drugs].
    Sentić M; Baresić M; Anić B; Bosnić D; Cerovec M; Mayer M; Smiljanić L; Cikes N
    Lijec Vjesn; 2010; 132(9-10):317-8. PubMed ID: 21261033
    [No Abstract]   [Full Text] [Related]  

  • 14. Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001).
    Furst DE; Keystone EC; Breedveld FC; Kalden JR; Smolen JS; Antoni CE; Burmester GR; Crofford LJ; Kavanaugh A
    Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii2-5. PubMed ID: 11890647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of rheumatic diseases during pregnancy.
    Elliott AB; Chakravarty EF
    Postgrad Med; 2010 May; 122(3):213-21. PubMed ID: 20463432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconception Counseling.
    Østensen M
    Rheum Dis Clin North Am; 2017 May; 43(2):189-199. PubMed ID: 28390562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.
    Lee HH; Song IH; Friedrich M; Gauliard A; Detert J; Röwert J; Audring H; Kary S; Burmester GR; Sterry W; Worm M
    Br J Dermatol; 2007 Mar; 156(3):486-91. PubMed ID: 17300238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic therapy use and pregnancy outcomes in women with immune-mediated inflammatory rheumatic diseases.
    Brites L; Madeira N; Rodrigues J; Marona J; Martins N; Águeda A; Freitas R; Neto A; Capela S; Sequeira G; Ganhão S; Duarte C; Santiago M; Santos MJ
    Acta Reumatol Port; 2019; 44(4):266-272. PubMed ID: 32008032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antirheumatic therapy and reproduction. The influence on fertility, pregnancy and breast feeding].
    Ostensen M
    Z Rheumatol; 2006 May; 65(3):217-20, 222-4. PubMed ID: 16670813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
    Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME
    J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.